Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9926863rdf:typepubmed:Citationlld:pubmed
pubmed-article:9926863lifeskim:mentionsumls-concept:C0035298lld:lifeskim
pubmed-article:9926863lifeskim:mentionsumls-concept:C0024467lld:lifeskim
pubmed-article:9926863lifeskim:mentionsumls-concept:C0022116lld:lifeskim
pubmed-article:9926863lifeskim:mentionsumls-concept:C0025887lld:lifeskim
pubmed-article:9926863lifeskim:mentionsumls-concept:C1442080lld:lifeskim
pubmed-article:9926863lifeskim:mentionsumls-concept:C0457083lld:lifeskim
pubmed-article:9926863pubmed:issue18lld:pubmed
pubmed-article:9926863pubmed:dateCreated1999-4-13lld:pubmed
pubmed-article:9926863pubmed:abstractTextWe determined whether exogenous Mg2+ and/or mexiletine (Mex), which are reported to be neuroprotective agents, reduced neuronal energy requirements and protected against ischemia, using isolated rabbit retinas. Under non-ischemic conditions, Mex (300 microM) and the combination of Mg2+ (1 mM) plus Mex (300 microM) significantly reduced glucose utilization, by 19% and 31%, respectively. The combination of Mg2+ plus Mex, but not either agent alone, significantly reduced lactate production (by 18%; p < 0.05). When added during 2 h of ischemia (simulated by the reduction of oxygen from 95% to 15% and of glucose from 6 mM to 1 mM), Mg2+ plus Mex improved the recovery of glucose utilization (p < 0.01), lactate production (p < 0.05) and neuronal function (p < 0.05) for 3 h following return to control (post-ischemia/recovery) conditions. Thus reducing energy demands by blocking functions during temporary ischemia, protects neurons from irreversible functional damage.lld:pubmed
pubmed-article:9926863pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9926863pubmed:languageenglld:pubmed
pubmed-article:9926863pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9926863pubmed:citationSubsetIMlld:pubmed
pubmed-article:9926863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9926863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9926863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9926863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9926863pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9926863pubmed:statusMEDLINElld:pubmed
pubmed-article:9926863pubmed:monthDeclld:pubmed
pubmed-article:9926863pubmed:issn0959-4965lld:pubmed
pubmed-article:9926863pubmed:authorpubmed-author:OgilvyC SCSlld:pubmed
pubmed-article:9926863pubmed:authorpubmed-author:MaynardK IKIlld:pubmed
pubmed-article:9926863pubmed:authorpubmed-author:Quiñones-Hino...lld:pubmed
pubmed-article:9926863pubmed:issnTypePrintlld:pubmed
pubmed-article:9926863pubmed:day21lld:pubmed
pubmed-article:9926863pubmed:volume9lld:pubmed
pubmed-article:9926863pubmed:ownerNLMlld:pubmed
pubmed-article:9926863pubmed:authorsCompleteYlld:pubmed
pubmed-article:9926863pubmed:pagination4141-4lld:pubmed
pubmed-article:9926863pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:meshHeadingpubmed-meshheading:9926863-...lld:pubmed
pubmed-article:9926863pubmed:year1998lld:pubmed
pubmed-article:9926863pubmed:articleTitleMagnesium plus mexiletine inhibit energy usage and protect retinas against ischemia.lld:pubmed
pubmed-article:9926863pubmed:affiliationNeurosurgical Service, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.lld:pubmed
pubmed-article:9926863pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9926863pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:9926863pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9926863pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed